STATIN-FIBRATE REPORT: Focus on Safety

The mean dose of fluvastatin was 56 mg and the mean duration of exposure to combination therapy was 38 weeks. Safety measurements included frequency of adverse events and clinically relevant elevations in liver function tests (LFTs-ALT and AST) and CK. Of the 1,018 patients, only 688 had adverse event information available. ................
................